Here are five things to know:
1. Ms. Stafslien has more than 20 years of experience as a legal advisor to medical technology companies. She previously served as general counsel and corporate secretary for CareFusion.
2. In her new role, Ms. Stafslien will be responsible for overseeing NuVasive’s global legal function. She’ll report to Chairman and CEO Gregory T. Lucier.
3. Ms. Stafslien will have a spot on the company’s executive leadership team.
4. Throughout her career, Ms. Stafslien has experience leading the legal team of Cardinal Health and had a private practice with Brobeck, Phleger & Harrison.
5. She serves on the advisory board of the chemical and biological engineering department of Northwestern University in Chicago.
More articles on orthopedic devices:
Global orthopedic devices market to hit $41.2 by 2019: 8 highlights
Zimmer Biomet, SI-BONE, Amendia & more: 10 key notes
Global market for cervical total disc replacement devices to reach $1.75B by 2021: 5 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
